Unaudited Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Jun. 30, 2016	Jun. 30, 2015
Cash flows from operating activities:
Net income (loss)	$ 5,547	$ (12,161)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	9,434	8,619
Stock-based compensation expense	5,844	4,546
Inventory impairments and abandonments	15,098	249
Deferred and other income tax expense (benefit)	619	(731)
Gain on sale of fixed assets	(893)	0
Change in allowance for doubtful accounts	(186)	47
Equity in (income) loss of unconsolidated entities and marketable securities	(71)	1,453
Cash distributions of income from unconsolidated entities and marketable securities	99	99
Loss on extinguishment of debt	155	0
Changes in operating assets and liabilities:
Increase in accounts receivable	(13,340)	(10,500)
Decrease (increase) in income tax receivable	198	(216)
Increase in inventory	(35,298)	(245,169)
Increase in other assets	(1,405)	(2,287)
(Decrease) increase in trade accounts payable	(4,090)	20,826
Decrease in other liabilities	(12,580)	(2,716)
Other changes	0	(199)
Net cash used in operating activities	(30,869)	(238,140)
Cash flows from investing activities:
Capital expenditures	(9,718)	(11,756)
Proceeds from sale of fixed assets	2,549	0
Investments in unconsolidated entities	(3,138)	(2,651)
Return of capital from unconsolidated entities and marketable securities	1,142	24,245
Increase in Restricted Cash	(4,679)	(3,806)
Decrease in Restricted Cash	24,734	28,936
Net cash provided by investing activities	10,890	34,968
Cash flows from financing activities:
Repayment of debt	(239,312)	(11,934)
Proceeds from issuance of new debt	137,900	0
Repayment of borrowings from credit facility	(50,000)	(30,000)
Borrowings from credit facility	50,000	50,000
Debt issuance costs	(2,545)	(126)
Other financing activities	(438)	(170)
Net cash (used in) provided by financing activities	(104,395)	7,770
Decrease in cash and cash equivalents	(124,374)	(195,402)
Cash and cash equivalents at beginning of period	251,583	324,154
Cash and cash equivalents at end of period	$ 127,209	$ 128,752